Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Gilead Takes Lead on Crohn's over AbbVie
Gilead Takes Lead on Crohn's over AbbVie
Gilead Takes Lead on Crohn's over AbbVie
Submitted by
admin
on November 28, 2016 - 11:33pm
Source:
Investopedia
News Tags:
Gilead Sciences
AbbVie
Crohn's Disease
Galapagos
filgotinib
ABT-494
Headline:
Gilead Takes Lead on Crohn's over AbbVie
Do Not Allow Advertisers to Use My Personal information
